Ownership Summary
Quarter ending 30 Jun, 2026
Clearmind Medicine Inc. (NASDAQ:CMND) showed up in the 13F filings of 6 institutional investors as of June 2026.
- They owned 385.6% of outstanding stock in June 2026, up from 35.4% the prior quarter.
- They increased total shares held in Clearmind Medicine by 0.0% from last quarter, and the number of investors in CMND decreased 33.33% annually.
- Activity in CMND broke down as 6 buyers, 0 sellers, and 0 unchanged among 6 total holders.
- Institutional investors collectively held 49.01K shares in Clearmind Medicine as of June 2026, up by 49.01K shares quarter on quarter, and up 34.34K shares year over year.
- As of June 30, 2026, HRT FINANCIAL LP held the largest stake in Clearmind Medicine with 35.14K shares, accounting for 276.52% of total shares outstanding.
- Leading buyers of Clearmind Medicine shares for the quarter ending June 2026 were HRT FINANCIAL LP (35.14K), CITADEL ADVISORS LLC (11.71K), AdvisorShares Investments LLC (1.17K), Morgan Stanley (700), Royal Bank Of Canada (287).
- Business Quant data shows the 6 biggest positions in Clearmind Medicine as of June 2026 are held by HRT FINANCIAL LP (35.14K), CITADEL ADVISORS LLC (11.71K), AdvisorShares Investments LLC (1.17K), Morgan Stanley (700), Royal Bank Of Canada (287), Caitong International Asset Management Co., Ltd (1).